Nduati E

Validation of high-throughput oxford nanopore technology for HIV-1 transmitted/founder virus identification.Byamukama D Ndekezi C Omara D Nakyanzi A Natwijuka F Kato F Mugaba S Kimuda MP Kapaata A Nduati E Kaleebu P Balinda SN
Int J Infect Dis, (2025). 161:108138

Advancing the course of HIV genomics research in Africa.Agamah FE Arbuthnot P Tindana P Munung NS Kasule M Ghansah A Mosepele M Gaolathe T Kekitiinwa A Nduati E Jumare J Gomez-Olive FX Liebenberg L Dandara C Osawe S Julius R Muzambi T Natus T Omumbo J Mayne E Abimiku A Richardson S Matshaba M Skelton M
BMJ Glob Health, (2025). 10:

Unique genetic signatures in HIV-1 subtype A1 and A1D recombinant envelope glycoprotein distinguish contemporary transmitted/founder viruses from historical strains in East Africa.Kato F Kapaata A Galiwango R Nakyanzi A Ndekezi C Natwijuka F Omara D Obuku AE Foley B Kaleebu P Nduati E Balinda SN
Front Microbiol, (2025). 16:1632581

Safety and broad immunogenicity of HIVconsvX conserved mosaic candidate T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 006: a double-blind, randomised, placebo-controlled phase 1 trial in healthy adults living without HIV-1 in eastern and southern Africa.Chanda C Kibengo F Mutua M Ogada F Muturi-Kioi V Akis Yildirim BM Amondi M Baines A Basajja V Borthwick N Bosire K Chambula E Chetty P Chinyenze K Chirro O Crook A De Bont J Fernandez N Ejou P Farah B Glaze M Gombe B Gumbe A Hayes P Itwi S Juma S Kabarambi A Kabengele C Kafeero P Kakande A Kanungi J Kidega W King D Mahira R Malogo R Matsoso M Michelo C Moyo A Mugaba S Mugenya I Muhumuza P Mujadidi YF Muriuki M Musale V Mutua G Muwowo M Mwale F Mwangi I Nakimbugwe M Namuyanja A Nduati E Nielsen L Nyange J Oino G Okech B Omosa-Manyonyi G Otieno D Palmer S Phiri H Ramko K Rutishauser RL Sayeed E Sajabi R Serwanga J GTWee E Wenden C Cicconi P Fast P Gilmour J Jaoko W Kaleebu P Kilembe W Kuipers H Sanders EJ Hanke T
Lancet Microbe, (2025). 6:101041

Evaluation of population immunity against SARS-CoV-2 variants, EG.5.1, FY.4, BA.2.86, JN.1, JN.1.4, and KP.3.1.1 using samples from two health demographic surveillance systems in Kenya.Lugano D Kutima B Kimani M Sigilai A Gitonga J Karani A Akech D Karia B Ziraba AK Maina A Lambisia A Omuoyo D Mugo D Lucinde R Owuor S Konyino G Newman J Bailey D Nduati E Githinji G Agoti CN Bejon P Scott JAG Agweyu A Kagucia W Warimwe GM Sande C Ochola-Oyier LI Nyagwange J
BMC Infect Dis, (2024). 24:1474

Profiling IgG and IgA antibody responses during vaccination and infection in a high-risk gonorrhoea population.Stejskal L Thistlethwaite A Ramirez-Bencomo F Rashmi S Harrison O Feavers IM Maiden MCJ Jerse A Barnes G Chirro O Chemweno J Nduati E Cehovin A Tang C Sanders EJ Derrick JP
Nat Commun, (2024). 15:6712

Exposure to common infections may shape basal immunity and potentially HIV-1 acquisition amongst a high-risk population in Coastal Kenya.Fwambah L Andisi C Streatfield C Bromell R Hare J Esbjornsson J Ndung'u T Sanders EJ Hassan AS Nduati E
Front Immunol, (2024). 14:1283559

Serum immunoglobulin G and mucosal immunoglobulin A antibodies from prepandemic samples collected in Kilifi, Kenya, neutralize SARS-CoV-2 in vitro.Nyagwange J Kutima B Mwai K Karanja HK Gitonga JN Mugo D Sein Y Wright D Omuoyo DO Nyiro JU Tuju J Nokes DJ Agweyu A Bejon P Ochola-Oyier LI Scott JAG Lambe T Nduati E Agoti C Warimwe GM
Int J Infect Dis, (2023). 127:11-16

Assessment of a diverse panel of transmitted/founder HIV-1 infectious molecular clones in a luciferase based CD8 T-cell mediated viral inhibition assay.Fernandez N Hayes P Makinde J Hare J King D Xu R Rehawi O Mezzell AT Kato L Mugaba S Serwanga J Chemweno J Nduati E Price MA Osier F Ochsenbauer C Yue L Hunter E Gilmour J Iavi protocol C investigators
Front Immunol, (2022). 13:1029029

Atypical B cells are part of an alternative lineage of B cells that participates in responses to vaccination and infection in humans.Sutton HJ Aye R Idris AH Vistein R Nduati E Kai O Mwacharo J Li X Gao X Andrews TD Koutsakos M Nguyen THO Nekrasov M Milburn P Eltahla A Berry AA Kc N Chakravarty S Sim BKL Wheatley AK Kent SJ Hoffman SL Lyke KE Bejon P Luciani F Kedzierska K Seder RA Ndungu FM Cockburn IA
Cell Rep, (2021). 34:108684

Symptom-based Scoring for Acute Human Immunodeficiency Virus.Sanders EJ Kigoro A Thiong'o A Nduati E Graham SM
Clin Infect Dis, (2019). 69:736-737

Cytomegalovirus viraemia is associated with poor growth and T-cell activation with an increased burden in HIV-exposed uninfected infants.Garcia-Knight MA Nduati E Hassan AS Nkumama I Etyang TJ Hajj NJ Gambo F Odera D Berkley JA Rowland-Jones SL Urban B
AIDS, (2017). 31:1809-1818

Altered Memory T-Cell Responses to Bacillus Calmette-Guerin and Tetanus Toxoid Vaccination and Altered Cytokine Responses to Polyclonal Stimulation in HIV-Exposed Uninfected Kenyan Infants.Garcia-Knight MA Nduati E Hassan AS Gambo F Odera D Etyang TJ Hajj NJ Berkley JA Urban BC Rowland-Jones SL
PLoS One, (2015). 10:e0143043

HIV-exposed uninfected children: a growing population with a vulnerable immune system?.Afran L Garcia Knight M Nduati E Urban BC Heyderman RS Rowland-Jones SL
Clin Exp Immunol, (2014). 176:11-22

The plasma concentration of the B cell activating factor is increased in children with acute malaria.Nduati E Gwela A Karanja H Mugyenyi C Langhorne J Marsh K Urban BC
J Infect Dis, (2011). 204:962-70

Effect of folate derivatives on the activity of antifolate drugs used against malaria and cancer.Nduati E Diriye A Ommeh S Mwai L Kiara S Masseno V Kokwaro G Nzila A
Parasitol Res, (2008). 102:1227-34

2,4-diaminopteridine-based compounds as precursors for de novo synthesis of antifolates: a novel class of antimalarials.Nduati E Hunt S Kamau EM Nzila A
Antimicrob Agents Chemother, (2005). 49:3652-7

Why has the dihydrofolate reductase 164 mutation not consistently been found in Africa yet?.Nzila A Ochong E Nduati E Gilbert K Winstanley P Ward S Marsh K
Trans R Soc Trop Med Hyg, (2005). 99:341-6

In vitro activities of 2,4-diaminoquinazoline and 2,4-diaminopteridine derivatives against Plasmodium falciparum.Ommeh S Nduati E Mberu E Kokwaro G Marsh K Rosowsky A Nzila A
Antimicrob Agents Chemother, (2004). 48:3711-4

Plasmodium falciparum: in vitro activity of sulfadoxine and dapsone in field isolates from Kenya: point mutations in dihydropteroate synthase may not be the only determinants in sulfa resistance.Mberu EK Nzila AM Nduati E Ross A Monks SM Kokwaro GO Watkins WM Hopkins Sibley C
Exp Parasitol, (2002). 101:90-6